Hepatitis Monthly

Published by: Kowsar

Controversies in the Screening of Hepatitis C Virus Among First-Degree Family Members of the Affected Patients

Parivash Davoodian 1 , * and Hamidreza Mahboobi 1
Authors Information
1 Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
Article information
  • Hepatitis Monthly: March 2018, 18 (3); e45233
  • Published Online: February 5, 2017
  • Article Type: Letter
  • Received: December 31, 2016
  • Revised: January 23, 2017
  • Accepted: January 31, 2017
  • DOI: 10.5812/hepatmon.45233

To Cite: Davoodian P, Mahboobi H. Controversies in the Screening of Hepatitis C Virus Among First-Degree Family Members of the Affected Patients, Hepat Mon. 2018 ; 18(3):e45233. doi: 10.5812/hepatmon.45233.

Copyright © 2017, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. Alavian SM, Hajarizadeh B, Bagheri Lankarani K, Sharafi H, Ebrahimi Daryani N, Merat S, et al. Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline. Hepat Mon. 2016;16(8). ee40959. doi: 10.5812/hepatmon.guideline. [PubMed: 27799966].
  • 2. Mousavi SF, Moosavy SH, Alavian SM, Eghbali H, Mahboobi H. Distribution of hepatitis C virus genotypes among patients with hepatitis C virus infection in hormozgan, iran. Hepat Mon. 2013;13(12). ee14324. doi: 10.5812/hepatmon.14324. [PubMed: 24403914].
  • 3. Hesamizadeh K, Sharafi H, Rezaee-Zavareh MS, Behnava B, Alavian SM. Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals. Hepat Mon. 2016;16(4). ee37089. doi: 10.5812/hepatmon.37089. [PubMed: 27275164].
  • 4. Alavian SM, Rezaee-Zavareh MS. The Middle East and hepatitis C virus infection: does it need special attention? Lancet Infect Dis. 2016;16(9):1006-7. doi: 10.1016/S1473-3099(16)30264-X. [PubMed: 27684342].
  • 5. Kargar Kheirabad A, Bahri F, Kargar M, Ghasemzadeh I. Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern Iran. Hepat Mon. 2016;16(10). ee40375. doi: 10.5812/hepatmon.40375. [PubMed: 27882069].
  • 6. Makiani MJ, Davoodian P, Abedi F, Hossini M, Zare S, Rahimi S, et al. AIDS and hepatitis B and C high risk behaviors among 15 to 45 years old individuals in Bandar Abbas (Iran) in 2012. Electron Physician. 2014;6(3):884-9. doi: 10.14661/2014.883-889. [PubMed: 25763163].
  • 7. WHO Guidelines Approved by the Guidelines Review Committee . Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection: Updated Version. Geneva; 2016.
  • 8. Moezzi M, Imani R, Karimi A, Pourheidar B. Hepatitis C Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province of Iran in 2013. J Clin Diagn Res. 2015;9(10):LC13-7. doi: 10.7860/JCDR/2015/14986.6694. [PubMed: 26557546].
  • 9. Plancoulaine S, Mohamed MK, Arafa N, Bakr I, Rekacewicz C, Tregouet DA, et al. Dissection of familial correlations in hepatitis C virus (HCV) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection. Gut. 2008;57(9):1268-74. doi: 10.1136/gut.2007.140681. [PubMed: 18480169].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments